ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse

LIXISENATIDUM

Active substance (INN) · ATC A10AE54 · 2 products authorised in Romania
◀ Back
1

Protocols it appears in

As a medicine of the protocol (in the title) or only mentioned in the text

CodeProtocolStatusRoleSublistGP
A10AE54 COMBINATII (INSULINE GLARGINE+LIXISENATIDUM) In force medicine of the protocol C2-P5 NO
A10BX10 LIXISENATIDUM In force medicine of the protocol C2-P5 YES
AE01E PROTOCOL TERAPEUTIC ÎN DIABETUL ZAHARAT In force mentioned in the text C2-P5
2

Authorised brand products (ANMDM)

The Romanian register of medicines for human use, updated daily

Brand nameFormStrengthHolderATCRx
SULIQUA 100 unitati/ml+33 micrograme/mlSOL. INJ. IN STILOU INJECTOR (PEN) PREUMPLUT100unitati/ml+33micrograme/mlSANOFI WINTHROP INDUSTRIE - FRANTAA10AE54PRF
SULIQUA 100 unitati/ml+50 micrograme/mlSOL. INJ. IN STILOU INJECTOR (PEN) PREUMPLUT100unitati/ml+50micrograme/mlSANOFI WINTHROP INDUSTRIE - FRANTAA10AE54PRF

Data extracted automatically from the documents published by CNAS (cnas.ro/protocoale-terapeutice) and from the ANMDM medicines register. For information only; the official text (the Ministry of Health / CNAS orders published in the Official Gazette) prevails. Protocol names and texts are shown in Romanian, as published.